Historical Valuation
Guardian Pharmacy Services Inc (GRDN) is now in the Overvalued zone, suggesting that its current forward PE ratio of 28.46 is considered Overvalued compared with the five-year average of 24.95. The fair price of Guardian Pharmacy Services Inc (GRDN) is between 24.18 to 29.25 according to relative valuation methord. Compared to the current price of 30.94 USD , Guardian Pharmacy Services Inc is Overvalued By 5.77%.
Relative Value
Fair Zone
24.18-29.25
Current Price：30.94
5.77%
Overvalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Guardian Pharmacy Services Inc (GRDN) has a current Price-to-Book (P/B) ratio of 10.18. Compared to its 3-year average P/B ratio of 8.91 , the current P/B ratio is approximately 14.24% higher. Relative to its 5-year average P/B ratio of 8.91, the current P/B ratio is about 14.24% higher. Guardian Pharmacy Services Inc (GRDN) has a Forward Free Cash Flow (FCF) yield of approximately 3.65%. Compared to its 3-year average FCF yield of 3.20%, the current FCF yield is approximately 13.94% lower. Relative to its 5-year average FCF yield of 3.20% , the current FCF yield is about 13.94% lower.
P/B
Median3y
8.91
Median5y
8.91
FCF Yield
Median3y
3.20
Median5y
3.20
Competitors Valuation Multiple
AI Analysis for GRDN
The average P/S ratio for GRDN competitors is 0.77, providing a benchmark for relative valuation. Guardian Pharmacy Services Inc Corp (GRDN.N) exhibits a P/S ratio of 1.28, which is 67.36% above the industry average. Given its robust revenue growth of 20.05%, this premium appears sustainable.
Performance Decomposition
AI Analysis for GRDN
1Y
3Y
5Y
Market capitalization of GRDN increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of GRDN in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is GRDN currently overvalued or undervalued?
Guardian Pharmacy Services Inc (GRDN) is now in the Overvalued zone, suggesting that its current forward PE ratio of 28.46 is considered Overvalued compared with the five-year average of 24.95. The fair price of Guardian Pharmacy Services Inc (GRDN) is between 24.18 to 29.25 according to relative valuation methord. Compared to the current price of 30.94 USD , Guardian Pharmacy Services Inc is Overvalued By 5.77% .
What is Guardian Pharmacy Services Inc (GRDN) fair value?
GRDN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Guardian Pharmacy Services Inc (GRDN) is between 24.18 to 29.25 according to relative valuation methord.
How does GRDN's valuation metrics compare to the industry average?
The average P/S ratio for GRDN's competitors is 0.77, providing a benchmark for relative valuation. Guardian Pharmacy Services Inc Corp (GRDN) exhibits a P/S ratio of 1.28, which is 67.36% above the industry average. Given its robust revenue growth of 20.05%, this premium appears sustainable.
What is the current P/B ratio for Guardian Pharmacy Services Inc (GRDN) as of Jan 10 2026?
As of Jan 10 2026, Guardian Pharmacy Services Inc (GRDN) has a P/B ratio of 10.18. This indicates that the market values GRDN at 10.18 times its book value.
What is the current FCF Yield for Guardian Pharmacy Services Inc (GRDN) as of Jan 10 2026?
As of Jan 10 2026, Guardian Pharmacy Services Inc (GRDN) has a FCF Yield of 3.65%. This means that for every dollar of Guardian Pharmacy Services Inc’s market capitalization, the company generates 3.65 cents in free cash flow.
What is the current Forward P/E ratio for Guardian Pharmacy Services Inc (GRDN) as of Jan 10 2026?
As of Jan 10 2026, Guardian Pharmacy Services Inc (GRDN) has a Forward P/E ratio of 28.46. This means the market is willing to pay $28.46 for every dollar of Guardian Pharmacy Services Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Guardian Pharmacy Services Inc (GRDN) as of Jan 10 2026?
As of Jan 10 2026, Guardian Pharmacy Services Inc (GRDN) has a Forward P/S ratio of 1.28. This means the market is valuing GRDN at $1.28 for every dollar of expected revenue over the next 12 months.